Project Grant R15HL177692
Award Date
1/15/25
Completion Date
12/31/27
Dollars Obligated
$891K
Federal Agency
National Heart Lung and Blood Institute
Federal Grant Program
93.837
Assistance Type
Project Grant
Place of Performance
Ohio, USA
Similar Awards
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under CFDA Program 93.837 - Cardiovascular Diseases Research provides $704,913 to The Johns Hopkins University to study the role of dysregulated mitophagy, or mitochondrial quality control, in the cardiac dysfunction observed in Barth syndrome. The research aims to: 1) Evaluate the effect of tafazzin (TAZ) deficiency, which underlies Barth syndrome, on mechanisms of mitochondrial quality control; 2) Determine the...
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $167,400 Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837) to the Regents of the University of Michigan. The 5-year grant, which commenced on May 15, 2025, supports research by Dr. Joshua Meisner, a pediatric cardiologist and physician-scientist, to elucidate the mechanical and metabolic pathways underlying hypertrophic cardiomyopathy (HCM) caused by MYBPC3 gene mutations. The research aims to develop...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) supports research into the role of mitochondrial signaling between cardiomyocytes and fibroblasts in cardiac fibrosis. The $639,621 award, granted on May 15, 2025, will fund a research project led by Cleveland Clinic Lerner College of Medicine of Case Western Reserve University to investigate how intact mitochondria released from cardiomyocytes mediate...
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $385,000 Project Grant (CFDA 93.837 - Cardiovascular Diseases Research) to the RU School of Osteopathic Medicine in Pennsylvania. The 5-year grant, which commenced on January 20, 2025, aims to investigate the role of mitochondrial magnesium in regulating mitochondrial calcium uptake and its impact on ischemic reperfusion injury and heart failure. The key objectives are to: 1) define the mechanism by which oxidative stress...
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $125,568 Project Grant under the Cardiovascular Diseases Research (CFDA 93.837) program to Stanford University. The grant supports research to explore the molecular mechanisms governing the import and regulation of NAD+ within the mitochondrial matrix. This work aims to elucidate how mitochondria maintain adequate NAD+ levels and how this process may become dysregulated in heart failure, a major global health issue. The...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under CFDA 93.837 - Cardiovascular Diseases Research provides $777,258 to Beth Israel Deaconess Medical Center, Inc. (BIDMC) to conduct research focused on unraveling the mechanisms of heart failure in hypertrophic cardiomyopathy. The 5-year project aims to improve understanding of heart failure in hypertrophic cardiomyopathy through novel cardiac magnetic resonance imaging (CMR) phenotyping techniques,...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) provides $817,208 to The Broad Institute, Inc. to investigate the genetic basis and underlying mechanisms of heart failure. The research leverages high-throughput cellular analysis techniques, including cell painting and Perturb-seq, to functionally characterize genetic variants associated with heart failure risk. The goal is to rapidly...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) provides $465,000 in funding to Bloodworks, a non-profit organization based in Seattle, WA. The award supports research into the mechanisms by which chronic inflammation disrupts hemostatic function in sickle cell disease (SCD). Specifically, the project aims to investigate how TNF-driven inflammation in SCD blocks autophagy and mitophagy in...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under CFDA 93.837 - Cardiovascular Diseases Research provides $596,809 to Emory University to conduct research on the role of the mitochondrial protein MitoNEET in pulmonary hypertension (PH). The research aims to elucidate how MitoNEET regulates pulmonary artery smooth muscle cell function and mitochondrial bioenergetics, and to evaluate the potential of MitoNEET ligands as novel therapies for group 3 PH,...
This $231,552 Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) supports research by Northwestern University to investigate the role of the MTCH2 gene and its impact on heart failure and obesity. The key objectives are to: Determine if overexpressing the FUNDC2 protein in MTCH2 knockout mice can rescue the development of cardiomyopathy and impaired body composition. Measure how MTCH2 influences mitochondrial interactions...